Trials / Unknown
UnknownNCT01919151
Micrometastasis in Gastrointestinal Cancer
The Process of Metastasis in Colorectal Cancer Tumour Biology and Prognostic Factors in Pancreatic Cancer
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Oslo University Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Prognostic and predictive value of assessing the patients micrometastasis status in blood and bone marrow when diagnosed GI cancer. 2 different patient subgroups are currently studied, patients with cancer of the pancreas and patients with liver metastasis secondary to colorectal cancer. Our hypothesis is that patients with detective circulating tumor cells in the blood or disseminated tumour cells in their bone marrow at diagnosis have a more advanced disease than negative patients. This information may be of therapeutic interest.
Detailed description
Oncological and overall outcome of the included patients are consecutively registrated at the out-patient clinic. At end of follow-up these survival data are analysed according to the presence of tumor cells in blood and bone marrow, and the prognostic impact of their presence are assessed.
Conditions
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2013-12-01
- Completion
- 2015-12-01
- First posted
- 2013-08-08
- Last updated
- 2013-08-12
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT01919151. Inclusion in this directory is not an endorsement.